Nektar Therapeutics is a San Francisco-based biopharmaceutical company dedicated to the discovery and development of innovative therapies for significant unmet medical needs across diverse disease areas, including cancer, autoimmune disorders, and chronic pain. The company boasts a robust clinical pipeline and utilizes proprietary drug development technologies designed to improve both the efficacy and safety profiles of its therapeutics. With additional operational facilities in Huntsville, Alabama, and Hyderabad, India, Nektar emphasizes its commitment to advancing global health solutions and strategically positioning itself within the biotechnology sector.